 |
|
Therapeutic Studies in Experimental Chemical Injury of the Cornea1. Calsulfhydryl (Hydrosulphosol) Studies
GUSTAV C. BAHN, M.D.;
JAMES H. ALLEN, M.D.
AMA Arch Ophthalmol. 1955;54(1):22-27.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
This investigation is part of a systematic survey to determine the efficacy of current and newly developed methods of treating chemical corneal injuries. From the gamut of drugs available for use in chemical burns, calsulfhydryl (Hydrosulphosol) was selected for early evaluation because of its relative newness as a therapeutic agent, and because of the wide difference of opinion as to its clinical value. Either chemical or mechanical rupture of cell membranes increases the oxidative activity of the damaged tissue. Supply of a supplementary reducing agent tends to counteract this effect and to restore a more nearly normal oxidation-reduction balance in the aerobic enzyme systems of the corneal epithelium. Free sulfhydryl groups, which contain readily available hydrogen and sulfur, theoretically provide the necessary reductive power. Calsulfhydryl, which contains a fairly high concentration of free sulfhydryl groups, has been recommended in the treatment of almost all types of corneal lesions on the
. . . [Full Text PDF of this Article]
Author Affiliations
New Orleans
From the Department of Ophthalmology, Tulane University of Louisiana School of Medicine.
Footnotes
Submitted for publication May 3, 1955.
This study was supported by funds provided under contract AF 18 (600)-304 with the U. S. A. F. School of Aviation Medicine, Randolph Field, Texas.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
